Chlorine in PDB 9mei: Crystal Structure of Sars-Cov-2 Mpro Mutant L50F E166V with Pfizer Intravenous Inhibitor Pf-00835231

Enzymatic activity of Crystal Structure of Sars-Cov-2 Mpro Mutant L50F E166V with Pfizer Intravenous Inhibitor Pf-00835231

All present enzymatic activity of Crystal Structure of Sars-Cov-2 Mpro Mutant L50F E166V with Pfizer Intravenous Inhibitor Pf-00835231:
3.4.22.69;

Protein crystallography data

The structure of Crystal Structure of Sars-Cov-2 Mpro Mutant L50F E166V with Pfizer Intravenous Inhibitor Pf-00835231, PDB code: 9mei was solved by S.N.Zvornicanin, A.M.Shaqra, C.A.Schiffer, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

*Resolution Low / High (Å)*	33.53 / 1.84
*Space group*	P 1 2₁ 1
*Cell size a, b, c (Å), α, β, γ (°)*	55.279, 99.464, 58.983, 90, 108.02, 90
*R / R_free (%)*	17 / 21.9

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Crystal Structure of Sars-Cov-2 Mpro Mutant L50F E166V with Pfizer Intravenous Inhibitor Pf-00835231 (pdb code 9mei). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Crystal Structure of Sars-Cov-2 Mpro Mutant L50F E166V with Pfizer Intravenous Inhibitor Pf-00835231, PDB code: 9mei:

Chlorine binding site 1 out of 1 in 9mei

Go back to

Chlorine Binding Sites List in 9mei

Chlorine binding site 1 out of 1 in the Crystal Structure of Sars-Cov-2 Mpro Mutant L50F E166V with Pfizer Intravenous Inhibitor Pf-00835231

Mono view

Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of Sars-Cov-2 Mpro Mutant L50F E166V with Pfizer Intravenous Inhibitor Pf-00835231 within 5.0Å range:

probe	atom	residue	distance (Å)	B	Occ
B:Cl402 b:66.3 occ:1.00	H9	B:V2M401	3.8	34.0	0.5
	C9	B:V2M401	4.1	28.5	0.5
	C9	B:V2M401	4.1	28.5	0.5
	H28	B:V2M401	4.1	41.6	0.5
	N8	B:V2M401	4.2	29.1	0.5
	H26	B:V2M401	4.2	39.4	0.5
	H28	B:V2M401	4.2	41.6	0.5
	N8	B:V2M401	4.2	29.1	0.5
	C10	B:V2M401	4.3	32.2	0.5
	NE2	B:GLN189	4.3	37.0	1.0
	C10	B:V2M401	4.3	32.2	0.5
	CG1	B:VAL166	4.4	29.8	1.0
	H7	B:V2M401	4.4	34.9	0.5
	C12	B:V2M401	4.4	29.9	0.5
	O22	B:V2M401	4.4	25.3	0.5
	H26	B:V2M401	4.4	39.5	0.5
	C7	B:V2M401	4.4	29.2	0.5
	O22	B:V2M401	4.5	25.5	0.5
	O13	B:V2M401	4.5	19.8	0.5
	C7	B:V2M401	4.5	29.2	0.5
	C11	B:V2M401	4.5	29.9	0.5
	N14	B:V2M401	4.5	28.4	0.5
	C11	B:V2M401	4.5	29.9	0.5
	H7	B:V2M401	4.6	34.9	0.5
	C12	B:V2M401	4.6	29.9	0.5
	H24	B:V2M401	4.6	34.5	0.5
	H8	B:V2M401	4.7	38.6	0.5
	H8	B:V2M401	4.8	38.6	0.5
	H24	B:V2M401	4.8	34.5	0.5

Reference:

S.N.Zvornicanin, A.M.Shaqra, C.A.Schiffer. Crystal Structure of Sars-Cov-2 Mpro Mutant L50F E166V with Pfizer Intravenous Inhibitor Pf-00835231 To Be Published.

Page generated: Sun Jul 13 17:13:35 2025

Last articles

Cu in 1V6P
Cu in 1WAE
Cu in 1WA2
Cu in 1W8E
Cu in 1WA1
Cu in 1WA0
Cu in 1W7C
Cu in 1W6W
Cu in 1W6L
Cu in 1W77

	© Copyright 2008-2020 by atomistry.com
Home \| Site Map \| Copyright \| Contact us \| Privacy